TotalMarketCap

Larimar Therapeutics

LRMRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$244.644 M

$2.36 -14.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Larimar Therapeutics (LRMR) has a market capitalization of $244.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$165.7M

Loss-making

Shares outstanding

103,882,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #230EvommuneEVMN$262.8M
  2. #231BioAge LabsBIOA$254.3M
  3. #232Larimar TherapeuticsLRMR$244.6M
  4. #233Bicycle TherapeuticsBCYC$243.9M
  5. #234Lifecore Biomedical, Inc. DeLFCR$242.4M

What if Larimar Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$271,814.36

Per share 115,420× higher

Bitcoin $1.53T

$14,707.40

Per share 6,245× higher

Apple $5.02T

$48,283.03

Per share 20,502× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Larimar Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.